The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory (R/R) acute myeloid ...

Tenpoint Therapeutics, Ltd. ("Tenpoint"), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announces that the ...

GSK plc GSK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval of its ...

This patent strengthens Renovaro's AI and machine learning intellectual property portfolio by protecting novel methods for ...

The webcast of the event will be accessible from News & Events page of the I-Mab website for 90 days.

SMMT's HARMONi trial shows PFS benefits for ivonescimab in EGFR-mutant NSCLC, but lack of proven overall survival raises ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

Discover breakthrough medications that effectively treat nerve pain. Learn about prescription drugs, over-the-counter options ...

Recce receives firm commitments to place the full shortfall from its entitlement offer raising a total of $15.8 million to ..

Efforts to reform utilization management policies must prioritize clinical value, improve transparency, ensure alignment with ...

Breakthroughs in tricuspid and mitral valve repair signal progress in heart treatment. BEIJING, June 3, 2025 /PRNewswire/ -- ...

Mehari was sentenced to life in prison without parole for a minimum 25 years by since-retired Justice Sandy Park on March 12, ...